Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 39 for “"cGVHD"”.

  1. Blocking murine chronic graft versus host disease at different biological phases

    … However, chronic Graft-Versus-Host Disease (cGVHD) is commonly seen in long-term survivors of aHSCT and has become the leading cause of non-relapse mortality. Little improvement has been made to the clinical management of cGVHD in several decades, which relies on systemic immunosuppression …

    umn Repository record for Blocking murine chronic graft versus host disease at different biological phases (opens in a new tab)

  2. Metabolic regulation of the germinal center reaction in murine chronic graft versus host disease

    … of graft-versus-host-disease (GVHD). In cGVHD, donor derived T cells can differentiate into T follicular helper cells (TFH) that interact with germinal center B cells (GCB) to facilitate the production of alloreactive class switched antibodies. Patients refractory to the standard …

    umn Repository record for Metabolic regulation of the germinal center reaction in murine chronic graft versus host disease (opens in a new tab)

  3. Signaling pathways and novel therapeutic strategies for the treatment of murine chronic graft versus host disease

    … malignancies. Chronic graft-versus-host disease (cGVHD) is a long-term immune complication following aHSCT and a leading cause of non-relapse mortality. The standard of clinical management of broad immunosuppression by corticosteroids has been largely unchanged in several decades. With many …

    umn Repository record for Signaling pathways and novel therapeutic strategies for the treatment of murine chronic graft versus host disease (opens in a new tab)

  4. Altered B cell Toll-like Receptor 9 responses after the onset of paediatric chronic graft-versus host disease

    Chronic Graft-versus-Host disease (cGVHD) is a major complication after blood and marrow transplantation (BMT). B cells appear to play a role in cGVHD as evidenced in murine models and supported clinically by the success of B cell depletion treatment. Immunostimulatory microbial CpG-DNA responses …

    ubc Repository record for Altered B cell Toll-like Receptor 9 responses after the onset of paediatric chronic graft-versus host disease (opens in a new tab) Download PDF for Altered B cell Toll-like Receptor 9 responses after the onset of paediatric chronic graft-versus host disease (opens in a new tab)

  5. Understanding and treatment of murine chronic Graft-versus-Host Disease

    … tract and/or liver damages, and chronic GVHD (cGVHD) generally occurring beyond day 100 after transplantation, and affecting virtually any tissue, and often inducing tissue fibrosis. In recent years, significant progress has been achieved for aGVHD prevention. However, little improvement has …

    liege Repository record for Understanding and treatment of murine chronic Graft-versus-Host Disease (opens in a new tab)

  6. Single Cell Resolution of Chronic Graft-Versus-Host Disease

    Chronic graft-versus-host disease (cGVHD) remains a frequent and morbid outcome of allogeneic hematopoietic cell transplantation (HCT). Simply put, in cGVHD, the donor-derived immune system attacks healthy recipient tissue. Preceding tissue damage mediated by chemoradiotherapy and alloreactive T …

    washington Repository record for Single Cell Resolution of Chronic Graft-Versus-Host Disease (opens in a new tab)

  7. Chronische Graft-versus-Host-Erkrankung im pädiatrischen Setting - Identifikation von Charakteristika mit Fokus auf die Immunrekonstitution dendritischer Zellen

    Die cGvHD ist eine relevante Komplikation der aHSCT. Sie hat Einfluss auf die Morbidität und Mortalität nach der aHSCT. Die genaue Pathogenese ist unbekannt. Ein Einfluss dendritscher Zellen als Schlüsselzellen immunologischer Prozesse auf die Entstehung einer cGvHD ist wahrscheinlich. In dieser …

    wurz-thes Repository record for Chronische Graft-versus-Host-Erkrankung im pädiatrischen Setting - Identifikation von Charakteristika mit Fokus auf die Immunrekonstitution dendritischer Zellen (opens in a new tab)

  8. Adaptation and innovation of anti-cancer epigenetic targeting therapeutic strategies for the treatment of murine chronic graft vs host disease

    … in particular has proven difficult to manage. cGVHD is an auto-immune-like condition that arises as a result of donor-derived immune cells attacking the recipient tissues post-transplant. The current standard of treatment for cGVHD involves broad steroid immunosuppression, however in cases …

    umn Repository record for Adaptation and innovation of anti-cancer epigenetic targeting therapeutic strategies for the treatment of murine chronic graft vs host disease (opens in a new tab)

  9. Impacto da Infecção Prévia por Citomegalovírus (CMV) no Programa de Transcrição Gênica das células CD4+ em pacientes com Doença do Enxerto-contra-o-Hospedeiro Crônico (cDECH)

    … incluiu 18 pacientes com GVHD crônico ativo (cGVHD) e 20 pacientes considerados tolerantes. Tolerância foi definida como ausência de sinais e sintomas de cGVHD, assim como ausência de tratamento imunossupressor (IST) por pelo menos 2 meses com seguimento de 1 ano sem tratamento …

    brazil-ufrgs Repository record for Impacto da Infecção Prévia por Citomegalovírus (CMV) no Programa de Transcrição Gênica das células CD4+ em pacientes com Doença do Enxerto-contra-o-Hospedeiro Crônico (cDECH) (opens in a new tab)

  10. Symptoms, Cytokines, and Quality of Life of Patients with Chronic Graft-versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation

    Introduction: Chronic graft-versus-host disease (cGVHD) is a serious complication following allo-HSCT characterized by immune dysregulation, organ dysfunction, risk for infection, and distressing symptoms. Complications may include scleroderma, hepatic dysfunction and bronchiolitis obliterans. …

    vcu Repository record for Symptoms, Cytokines, and Quality of Life of Patients with Chronic Graft-versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation (opens in a new tab)

  11. Increasing safety of pediatric hematopoietic stem cell transplantation by targeted approaches to chronic graft-versus-host disease

    … including chronic graft-versus-host disease (cGVHD), a systemic condition that occurs when donor immune cells attack the recipient's tissues, leading to significant morbidity, with an incidence of 42% within three years and a non-relapse mortality rate of 30%. To date, most studies on cGvHD …

    ubc Repository record for Increasing safety of pediatric hematopoietic stem cell transplantation by targeted approaches to chronic graft-versus-host disease (opens in a new tab) Download PDF for Increasing safety of pediatric hematopoietic stem cell transplantation by targeted approaches to chronic graft-versus-host disease (opens in a new tab)

  12. Graft-Versus-Host-Disease nach NIH-Klassifikation bei Patienten mit Akuter Lymphatischer Leukämie

    … Graft-versus-Host-Disease (aGVHD bzw. cGVHD), einer von Spender-T-Zellen vermittelten Immunreaktion, bestimmt. Die Unterscheidung zwischen akuter und chronischer GVHD basiert historisch auf rein zeitlichen Kriterien, je nachdem, ob die ersten Symptome vor oder nach Tag 100 auftreten. Da …

    fu-berlin Repository record for Graft-Versus-Host-Disease nach NIH-Klassifikation bei Patienten mit Akuter Lymphatischer Leukämie (opens in a new tab)

  13. Ex vivo expandierte regulatorische T-Zellen als adjuvante Therapieoption bei chronischer Graft-versus-Host-Erkrankung

    … Die chronische Graft-versus-Host-Krankheit (cGVHD) ist eine Komplikation nach allogener Stammzelltransplantation (allo-HSCT), die mit hoher Morbidität und Mortalität einhergeht. Die gegenwärtig verfügbaren Medikamente sind nicht nur mit ausgeprägten Nebenwirkungen verbunden, sondern …

    fu-berlin Repository record for Ex vivo expandierte regulatorische T-Zellen als adjuvante Therapieoption bei chronischer Graft-versus-Host-Erkrankung (opens in a new tab)

  14. Pathological angiogenesis and endothelial dysfunction in Graft-versus-Host Disease after allogeneic hematopoietic stem cell transplantation

    … GvHD can occur acute (aGvHD) or chronic (cGvHD) as a systemic inflammatory disease, affecting various organs and tissues. Chronic inflammation subsequently leads to fibrosis and severe morbidity in cGvHD patients. Common therapeutic approaches aim to suppress alloreactive T cells, the …

    fu-berlin Repository record for Pathological angiogenesis and endothelial dysfunction in Graft-versus-Host Disease after allogeneic hematopoietic stem cell transplantation (opens in a new tab)

  15. Characterization and expansion of regulatory natural killer cells for the therapy of chronic graft-versus-host disease

    Chronic graft-versus-host disease (cGvHD) occurs in ~25% of pediatric and ~60% of adult Hematopoietic Stem Cell Transplant (HSCT) patients and is a major cause of mortality. In large study cohorts (~500 patients), our group has shown a CD56ᵇʳⁱᵍʰᵗPerforin⁻ Natural Killer population, consistent with …

    ubc Repository record for Characterization and expansion of regulatory natural killer cells for the therapy of chronic graft-versus-host disease (opens in a new tab) Download PDF for Characterization and expansion of regulatory natural killer cells for the therapy of chronic graft-versus-host disease (opens in a new tab)

  16. Espressione genica e Profilo Fosfoproteomico nella Malattia del Trapianto contro l'Ospite in bambini sottoposti a trapianto di cellule staminali ematopoietiche: confronto tra forma acuta e forma cronica

    … Si distinguono la forma acuta e cronica (aGvHD, cGvHD). Le conoscenze sulla patogenesi della forma acuta sono meglio conosciute rispetto a quelle sulla cGvHD, in cui diagnosi e gestione terapeutica rappresentano uno dei maggiori problemi post allo-TCSE. Non esistono ancora marcatori biologici in …

    catania Repository record for Espressione genica e Profilo Fosfoproteomico nella Malattia del Trapianto contro l'Ospite in bambini sottoposti a trapianto di cellule staminali ematopoietiche: confronto tra forma acuta e forma cronica (opens in a new tab)

  17. Therapeutischer Stellenwert der Gabe von kryokonservierten Spenderlymphozyten bei Patienten mit ausgewählten hämatologischen Erkrankungen nach allogener Stammzelltransplantation

    … nach DLI trat bei 35,6 % der Patienten auf, eine cGvHD bei 32,6 %. Dabei bedingte eine aGvHD eine signifikant höhere KI-NRM (p = < 0,001). Bei Auftreten einer cGvHD zeigten sich ein signifikant längeres OS (p = 0,040) sowie eine geringere KI-R (p = 0,001). Schlussfolgerungen: DLI sind eine …

    fu-berlin Repository record for Therapeutischer Stellenwert der Gabe von kryokonservierten Spenderlymphozyten bei Patienten mit ausgewählten hämatologischen Erkrankungen nach allogener Stammzelltransplantation (opens in a new tab)

  18. Etude de la reconstitution immunitaire après greffe de cellules souches hématopoïétiques : focus sur la fonction thymique et les lymphocytes T régulateurs

    … établissons également que la GVHD chronique (cGVHD) sévère possède des effets extrêmement délétères sur le thymus. Étant donné l’impact de la cGVHD sur le thymus et la reconstitution immunitaire, nous avons voulu comparer l’impact, sur ces deux paramètres, d’un conditionnement nonmyéloalbatif …

    liege Repository record for Etude de la reconstitution immunitaire après greffe de cellules souches hématopoïétiques : focus sur la fonction thymique et les lymphocytes T régulateurs (opens in a new tab) Restricted access

  19. Methods to enhance the efficacy of Regulatory T-cell therapies for acute and chronic Graft-versus-Host Disease

    … or Treg were efficacious in treating established cGVHD. Treatment efficacy was dependent upon enhancing Treg-mediated suppression of germinal centers. Importantly, IL-2/mAb complexes had the potential to drive Tcon proliferation, suggesting that Treg infusions may be safer for some cGVHD patients. …

    umn Repository record for Methods to enhance the efficacy of Regulatory T-cell therapies for acute and chronic Graft-versus-Host Disease (opens in a new tab)

  20. Analyse der Therapieergebnisse vor dem Hintergrund der Akut- und Spättoxizitäten bei Patienten mit akuter lymphatischer Leukämie nach Ganzkörperbestrahlung

    … Die chronische "Graft-versus- host"-Erkrankung (cGVHD) der Haut war die häufigste Spätreaktion (n = 33, 30%), gefolgt von 15,5% (17/110) pulmonaler cGVHD. Eine Lungenfibrose entwickelten 6 Patienten. Ophthalmologische Symptome berichteten 28% (31/110); 11% der Patienten (12/110) entwickelten eine …

    fu-berlin Repository record for Analyse der Therapieergebnisse vor dem Hintergrund der Akut- und Spättoxizitäten bei Patienten mit akuter lymphatischer Leukämie nach Ganzkörperbestrahlung (opens in a new tab)

Page 1 of 2